Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

CytomX Therapeutics (CTMX) Long-Term Debt Repayments: 2014-2015

Historic Long-Term Debt Repayments for CytomX Therapeutics (CTMX) over the last 1 years, with Dec 2015 value amounting to $40,000.

  • CytomX Therapeutics' Long-Term Debt Repayments fell 88.20% to $40,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2015, which is 144.19% up from last year.
  • Latest data reveals that CytomX Therapeutics reported Long-Term Debt Repayments of $40,000 as of Q4 2015, which was down 98.27% from $2.3 million recorded in Q3 2015.
  • CytomX Therapeutics' 5-year Long-Term Debt Repayments high stood at $2.3 million for Q3 2015, and its period low was $40,000 during Q4 2015.
  • Its 2-year average for Long-Term Debt Repayments is $681,200, with a median of $356,000 in 2015.
  • Data for CytomX Therapeutics' Long-Term Debt Repayments shows a maximum YoY slumped of 88.20% (in 2015) over the last 5 years.
  • Quarterly analysis of 2 years shows CytomX Therapeutics' Long-Term Debt Repayments stood at $339,000 in 2014, then slumped by 88.20% to $40,000 in 2015.
  • Its Long-Term Debt Repayments was $40,000 in Q4 2015, compared to $2.3 million in Q3 2015 and $362,000 in Q2 2015.